Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MGB BP 3

Next Previous
Drug Profile

MGB BP 3

Alternative Names: MGB-BP-3

Latest Information Update: 28 Jun 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator MGB Biopharma; University of Strathclyde
  • Developer MGB Biopharma
  • Class Anti-infectives; Antibacterials; DNA-binding proteins; Small molecules
  • Mechanism of Action Genetic transcription inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Clostridium difficile infections
  • No development reported Gram-positive infections; Skin and soft tissue infections

Most Recent Events

  • 28 Jun 2024 No recent reports of development identified for preclinical development in Gram-positive-infections in United Kingdom (IV)
  • 28 Jun 2024 No recent reports of development identified for preclinical development in Skin-and-soft-tissue-infections in United Kingdom (Topical)
  • 14 Jun 2022 MGB BP 3 is still in preclinical trials for skin and soft tissue infections in the United Kingdom (MGB Biopharma pipeline, June 2022)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top